Group I N = 13 | Group II N = 15 | Group III N = 81 | Group IV N = 45 | Group V N = 30 | P | |
---|---|---|---|---|---|---|
Age (yrs) | 63.3 ± 5.1 | 65.2 ± 7.4 | 76.0 ± 7.6 | 74.2 ± 8.7 | 75.2 ± 12.9 | 0.000 |
Male (%) | 8 (61.5) | 11 (73.3) | 48 (69.2) | 24 (53.3) | 18 (60.0) | NS |
BMI (kg/m2) | 25.9 ± 1.7 | 27.3 ± 5.2 | 25.6 ± 1.6 | 23.8 ± 2.9 | 23.9 ± 2.1 | 0.000 |
Risk factor (%) | ||||||
Hypertension | 3 (23.1) | 12 (80.0) | 51 (62.9) | 21 (46.7) | 27 (90.0) | 0.001 |
DM | 8 (61.5) | 9 (60.0) | 27 (33.3) | 15 (33.3) | 15 (50.0) | NS |
Smoking | 3 (23.1) | 5 (33.3) | 19 (23.5) | 17 (37.7) | 8 (26.7) | NS |
Hyperlipidemia | 8 (61.5) | 9 (60.0) | 18 (22.2) | 6 (13.3) | 9 (30.0) | 0.0003 |
IHD | 3 (23.1) | 7 (46.7) | 30 (37.0) | 22 (48.9) | 22 (73.3) | 0.005 |
Symptom at admission (%) | ||||||
Chest pain | 8 (61.5) | 10 (66/7) | 39 (50.0) | 29 (64.4) | 21 (70.0) | NS |
Dyspnea | 0 (0.0) | 1 (6.7) | 5 (6.4) | 3 (6.7) | 2 (6.7) | NS |
Killip class | 1.67 ± 1.1 | 1.67 ± 1.2 | 2.3 ± 1.2 | 2.5 ± 1.1 | 3.3 ± 0.5 | 0.000 |
Diagnosis | NS | |||||
UA | 8 (61.5) | 11 (73.3) | 54 (6.7) | 27 (60.0) | 21 (70.0) | NS |
NSTEMI | 5 (38.5) | 2 (13.3) | 23 (28.4) | 15 (33.3) | 6 (20.0) | NS |
STEMI | 0 (0) | 2 (13.3) | 4 (4.9) | 3 (6.7) | 3 (10.0) | NS |